Cystic Fibrosis Trial, Recruiting NCT07223255 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT07223255
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 3 and older (both boys and girls) who have been diagnosed with cystic fibrosis
  • Children whose nutritional status, measured by a standard weight-for-height score called BMI Z-score, is at -1 or higher (meaning not considered malnourished)
  • Children whose cystic fibrosis diagnosis has been confirmed either by finding 2 cystic fibrosis-related gene changes on a genetic test, or by a sweat test result above a certain level
  • Children with cystic fibrosis who have a pancreas that does not work well enough to digest food properly, and who are already taking digestive enzyme supplements (PERT)
  • Children with cystic fibrosis whose pancreas still works well enough for digestion, and who are not taking digestive enzyme supplements
  • Children who are eating a full diet made up of solid foods
  • Families who are willing to follow a Mediterranean-style diet exclusively for 6 months
  • Children who are able to attend regular cystic fibrosis clinic visits and any additional study appointments that may be required

Who may not be able to join:

  • Children who have malnutrition
  • Children who need to receive nutrition through any type of feeding tube
  • Children whose cystic fibrosis lung disease is not well controlled
  • Children who have advanced liver disease related to cystic fibrosis
  • Children who have another digestive or gut condition, such as coeliac disease, Crohn's disease, or other conditions affecting nutrient absorption (each case would be reviewed by the lead researcher)
  • Children who have significant food allergies or other allergies affecting the digestive system
  • Families who are not willing or able to follow the required diet plan for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 603-653-9666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Metagenomic sequencing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov